Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,076.47
930.87
675.49
493.15
346.73
233.12
134.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,076.47
930.87
675.49
493.15
346.73
233.12
134.46
Raw Material Cost
565.49
432.32
317.30
234.48
178.61
128.61
78.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
316.28
270.00
217.98
156.86
110.68
76.98
43.06
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
16.16
12.24
9.88
3.61
1.21
0.78
2.10
Selling and Distribution Expenses
184.96
202.54
123.13
94.62
53.76
32.99
23.88
Other Expenses
-17.89
-17.62
-14.72
-11.53
-7.95
-5.97
-3.71
Total Expenditure (Excl Depreciation)
904.00
740.87
521.09
374.31
264.73
179.69
110.39
Operating Profit (PBDIT) excl Other Income
172.5
190
154.4
118.80000000000001
82
53.4
24.1
Other Income
24.09
14.80
23.90
6.73
1.44
1.88
1.32
Operating Profit (PBDIT)
265.32
269.62
231.76
159.05
98.33
65.87
31.72
Interest
16.16
12.24
9.88
3.61
1.21
0.78
2.10
Exceptional Items
0.01
0.00
0.10
0.05
0.00
-0.11
0.00
Gross Profit (PBDT)
510.98
498.55
358.19
258.67
168.12
104.51
56.01
Depreciation
68.50
63.99
52.84
33.39
14.84
10.53
6.34
Profit Before Tax
180.67
193.40
169.14
122.10
82.28
54.46
23.28
Tax
6.97
10.50
10.43
13.31
8.12
6.52
3.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
177.41
184.76
156.47
105.66
72.46
47.40
20.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
177.41
184.76
156.47
105.66
72.46
47.40
20.72
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-8.40
-1.86
2.23
3.13
1.70
0.53
-0.56
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
169.01
182.90
158.70
108.79
74.16
47.93
20.16
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,100.64
1,040.01
896.93
761.95
189.10
116.64
75.24
Earnings per share (EPS)
1.58
1.65
1.4
0.94
0.65
0.42
0.18
Diluted Earnings per share
1.58
1.65
1.4
0.94
0.65
0.42
0.18
Operating Profit Margin (Excl OI)
16.05%
20.5%
22.95%
24.12%
23.66%
22.93%
17.9%
Gross Profit Margin
23.15%
27.65%
32.86%
31.53%
28.01%
27.88%
22.03%
PAT Margin
16.48%
19.85%
23.16%
21.43%
20.9%
20.33%
15.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 15.64% vs 37.81% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -7.60% vs 15.25% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -5.34% vs 22.56% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 32.79% vs 23.23% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,076.47
0
1,076.47
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,076.47
0
1,076.47
Raw Material Cost
565.49
0
565.49
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
316.28
0
316.28
Power Cost
0
0
0.00
Manufacturing Expenses
16.16
0
16.16
Selling and Distribution Expenses
184.96
0
184.96
Other Expenses
-17.89
0.00
-17.89
Total Expenditure (Excl Depreciation)
904.00
0
904.00
Operating Profit (PBDIT) excl Other Income
172.47
0.00
172.47
Other Income
24.09
0
24.09
Operating Profit (PBDIT)
265.32
0
265.32
Interest
16.16
0
16.16
Exceptional Items
0.01
0
0.01
Gross Profit (PBDT)
510.98
0
510.98
Depreciation
68.50
0
68.50
Profit Before Tax
180.67
0
180.67
Tax
6.97
0
6.97
Provisions and contingencies
0
0
0.00
Profit After Tax
177.41
0
177.41
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
177.41
0
177.41
Share in Profit of Associates
0
0
0.00
Minority Interest
-8.40
0
-8.40
Other related items
0.00
0.00
0.00
Consolidated Net Profit
169.01
0
169.01
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,100.64
0
1,100.64
Earnings per share (EPS)
1.58
0
1.58
Diluted Earnings per share
1.58
0
1.58
Operating Profit Margin (Excl OI)
16.05%
0%
0.00
16.05%
Gross Profit Margin
23.15%
0%
0.00
23.15%
PAT Margin
16.48%
0%
0.00
16.48%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 107.65 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 15.64% vs 37.81% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 16.90 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -7.60% vs 15.25% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.12 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -5.34% vs 22.56% in Dec 2023
Annual - Interest
Interest 1.62 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 32.79% vs 23.23% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.05%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






